Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1141-24-8

Post Buying Request

1141-24-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1141-24-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1141-24-8 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,1,4 and 1 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1141-24:
(6*1)+(5*1)+(4*4)+(3*1)+(2*2)+(1*4)=38
38 % 10 = 8
So 1141-24-8 is a valid CAS Registry Number.

1141-24-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-(4-bromophenyl)pentanedioic acid

1.2 Other means of identification

Product number -
Other names 3-(4-Brom-phenyl)-glutarsaeure

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1141-24-8 SDS

1141-24-8Relevant articles and documents

Investigation of a Photochromic Diarylethene with Electron-acceptor Attached

Li, Xiaochuan,Xu, Jingli,Zhang, Yaya,Son, Young-A.

, p. 102 - 111 (2015)

In this contribution, an electron acceptor attached diarylethene derivative was synthesized and fully characterized. The photochromic behavior was investigated in THF. Under exposure of UV and visible light cycles, the solution color can be switched betwe

SUBSTITUTED INDANONE COMPOUNDS AS GPR119 MODULATORS FOR THE TREATMENT OF DIABETES, OBESITY, DYSLIPIDEMIA AND RELATED DISORDERS

-

Page/Page column 46, (2015/11/17)

The present invention relates to indanone compounds. The indanone compounds are GPR119 modulators and useful for the prevention and/or treatment of diabetes, obesity, dyslipidemia and related disorders. The invention furthermore relates to the use of inda

ALLOSTERIC PROTEIN KINASE MODULATORS

-

Page/Page column 34-35, (2012/03/10)

The invention provides specific small molecule compounds that allosterically regulate the activity or modulate protein-protein interactions of AGC protein kinases and the Aurora family of protein kinases, methods for their production, pharmaceutical compositions comprising same, and their use for preparing medicaments for the treatment and prevention of diseases related to abnormal activities of AGC protein kinases or of protein kinases of the Aurora family.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1141-24-8